1873 — VIVA Biotech Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$1.29bn
- HK$1.85bn
- CNY2.16bn
- 53
- 62
- 31
- 46
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 281 | -356 | 348 | -459 | -56 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -249 | 409 | -116 | 758 | 277 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -20.1 | -90.9 | -307 | -98.4 | -48.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 46 | 32.2 | 77.8 | 386 | 383 |
Capital Expenditures | -56.2 | -593 | -565 | -250 | -188 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -234 | -3,246 | -304 | -123 | 627 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -290 | -3,838 | -869 | -373 | 439 |
Financing Cash Flow Items | -76.5 | -17.3 | -84.3 | -70.6 | 410 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 985 | 5,307 | -653 | -143 | -430 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 749 | 1,404 | -1,508 | -122 | 358 |